Skip to content
DraconiticResearch
Search Sources API
220,616 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY-NC 4.0Acta Paediatrica (Oslo, Norway : 1992)

Screening for Neurodevelopmental Disorders in Japanese 18‐ and 36‐Month Health Check‐Ups: Utility and Reproducibility of the ESSENCE‐Q

4 affiliations
  1. 1Faculty of Health Science Suzuka University of Medical Science Suzuka Mie Japan
  2. 2Kochi Gillberg Neuropsychiatry Centre, Kochi Treatment and Welfare Center Kochi Japan
  3. 3Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenburg Gothenburg Sweden
  4. 4Graduate School of Science and Technology, Hirosaki University Hirosaki Japan

Abstract

Aim: The ESSENCE Questionnaire (ESSENCE‐Q) helps detect early neurodevelopmental disorder signs across multiple developmental domains for timely intervention. We evaluated the feasibility, reliability, accuracy and reproducibility of ESSENCE‐Q in 18‐ and 36‐month Japanese infants and toddlers.

Methods: Longitudinal data from 1373 children who participated in 18‐ and/or 36‐month health check‐up were analysed. ESSENCE‐Q was completed independently by mothers (ESSENCE‐Q‐M), public health nurses (ESSENCE‐Q‐N) and psychologists (ESSENCE‐Q‐P). Its effectiveness was evaluated using receiver operating characteristic curves, and optimal cut‐off values were established.

Results: The overall neurodevelopmental disorder prevalence was 11.2%. The internal consistency of ESSENCE‐Q was good. ESSENCE‐Q‐P demonstrated the highest performance at 18 months. Both ESSENCE‐Q‐N and ESSENCE‐Q‐P demonstrated excellent performance at 36 months. ESSENCE‐Q‐M is not sufficient for standalone use.

Conclusion: ESSENCE‐Q is a highly useful and reproducible screening tool for professionals for 18‐ and 36‐month check‐ups. ESSENCE‐Q completed by mothers should be supplemented with professional assessments.

Related

  1. SET Domain Genes in Neurodevelopmental Disorders
    Aki Ohguri, Tadashi Nakagawa, Makiko Nakagawa +1
    GenesPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  2. Neurodevelopmental disorders in infants treated with anti-VEGF agents vs. laser photocoagulation or cryotherapy for ROP
    Inès Ben Ghezala, Caroline Bonnet, Caroline Conese +4
    Ophthalmology SciencePeer-reviewedLicence not statedZoology & animal behaviourHAL
  3. Parsing altered brain connectivity in neurodevelopmental disorders by integrating graph-based normative modeling and deep generative networks
    Rui Sherry Shen, Livia Rodrigues, Yusuf Osmanlıoğlu +6
    Communications MedicinePeer-reviewedCC BY-NC-ND 4.0Full text1 citedNeuroscienceCrossref
  4. Copy number variants (CNVs) interfere with human accelerated regions (HARs) in neurodevelopmental disorders: a large-scale cohort study
    Maria E. Iuditskaia, Ekaterina V. Semina, Elizaveta D. Pankratova +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGenetics & genomicsCrossref
  5. Vision In SyndrOmic Neurodevelopmental disorders-15q (VISiON-15q) study: eye tracking to supplement clinical examination for detection of cerebral/cortical visual impairment in children with Angelman and Duplication of 15q Syndromes
    Melinda Y. Chang, Sydney Jacobs, Katherine Granger +3
    Frontiers in human neurosciencePeer-reviewedCC BYFull textNeuroscienceEurope PMC
BibTeX
@article{hatakenaka2026screening,
  title = {{Screening for Neurodevelopmental Disorders in Japanese 18‐ and 36‐Month Health Check‐Ups: Utility and Reproducibility of the ESSENCE‐Q}},
  author = {Yuhei Hatakenaka and Koutaro Hachiya and Christopher Gillberg},
  journal = {Acta Paediatrica (Oslo, Norway : 1992)},
  year = {2026},
  month = jul,
  doi = {10.1111/apa.70688},
  url = {https://doi.org/10.1111/apa.70688},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Screening for Neurodevelopmental Disorders in Japanese 18‐ and 36‐Month Health Check‐Ups: Utility and Reproducibility of the ESSENCE‐Q
AU  - Yuhei Hatakenaka
AU  - Koutaro Hachiya
AU  - Christopher Gillberg
PY  - 2026
DA  - 2026/07/12
JO  - Acta Paediatrica (Oslo, Norway : 1992)
DO  - 10.1111/apa.70688
UR  - https://doi.org/10.1111/apa.70688
AB  - Aim: The ESSENCE Questionnaire (ESSENCE‐Q) helps detect early neurodevelopmental disorder signs across multiple developmental domains for timely intervention. We evaluated the feasibility, reliability, accuracy and reproducibility of ESSENCE‐Q in 18‐ and 36‐month Japanese infants and toddlers.  Methods: Longitudinal data from 1373 children who participated in 18‐ and/or 36‐month health check‐up were analysed. ESSENCE‐Q was completed independently by mothers (ESSENCE‐Q‐M), public health nurses (ESSENCE‐Q‐N) and psychologists (ESSENCE‐Q‐P). Its effectiveness was evaluated using receiver operating characteristic curves, and optimal cut‐off values were established.  Results: The overall neurodevelopmental disorder prevalence was 11.2%. The internal consistency of ESSENCE‐Q was good. ESSENCE‐Q‐P demonstrated the highest performance at 18 months. Both ESSENCE‐Q‐N and ESSENCE‐Q‐P demonstrated excellent performance at 36 months. ESSENCE‐Q‐M is not sufficient for standalone use.  Conclusion: ESSENCE‐Q is a highly useful and reproducible screening tool for professionals for 18‐ and 36‐month check‐ups. ESSENCE‐Q completed by mothers should be supplemented with professional assessments.
SN  - 0803-5253
SN  - 1651-2227
ER  -